Upload
others
View
0
Download
0
Embed Size (px)
Citation preview
Suthat Fucharoen1, Pranee Winichagoon1, Saovaros Svasti1, Orapan Sripichai1, Thongperm Munkongdee1, Kittiphong Paiboonsukwong1, Nantika Panutdaporn2, Kai Tang2
1Thalassemia Research Center, Institute of Molecular Biosciences, Mahidol University, Nakornpathom, Thailand, 2Nanyang Technological University, School of Biological Sciences, Singapore.
α-Thalassemia !
--THAI
ζ2 α1α2 θ1
0kb 10kb 20kb 30kb
ψζ1ψα2 ψα1inter- ζ HVR 3'HVR
--SEA
-α3.7-α4.2
2 α-globin genes deleted = α–thalassemia 11 α-globin gene deleted = α–thalassemia 2
beta gene cluster
11
β-Thalassemia
point mutation >200 mutations
KNOWN MUTATION: PCR-based methods 1. Electrophoresis:
- Gap-PCR: deletion- Amplification Refractory Mutation System
(ARMS)/Allele specific PCR: point mutation- PCR/RE digestion (RFLPs)
2. Allele-specific oligonucleotide hybridization: - Dot-blot hybridization (population screen) - Reverse dot-blot hybridization (individual screen)
MUTATION DETECTION (1)
UNKNOWN MUTATION1. Southern blot hybridization :
Large deletionRestriction Fragment Length Polymorphism (RFLP) -> Linkage analysis
2. Denaturing gradient gel electrophoresis (DGGE) & Single strand conformation polymorphism SSCP):
Point mutation3. PCR/Sequencing:
Point mutation
MUTATION DETECTION (2)
M -/- +/- +/+ Primer-F Primer-R
Dde I
Exon 1
A/G
300 bp
450 bp
150 bp
* 5’ 3’
A
Restriction Fragment Length Polymorphism (RFLP)
G
300
450
150
Gel electrophoresis
Allele specific PCR (ASPCR)
400
200
Gel electrophoresis
DN
A la
dder
N M
Normal
N M
Heterozygote
N M
Homozygote
Normal
Mutant
Normal
Mutant
Reverse
Reverse
Dot ASO probe on nylon membrane
Hybridization with denatured biotin label PCR product
Wash
Detection
Reverse Dot Blot Hybridization
= Biotinylated PCR
= Streptavin Akaline Phosphatase = BCIP/NBT (Substrate)
-28 CD17 CD26CD19 CD35IVSI-1 IVSI-5
N N N N NNN
N N N N NNN
-28 CD17 CD26CD19 CD35IVSI-1 IVSI-5
normal
Normal Probe
Mutant Probe
-28 CD17 CD26CD19 CD35IVSI-1 IVSI-5
N N M N NNN
N N N N NNN
-28 CD17 CD26CD19 CD35IVSI-1 IVSI-5
CD26 heterozygote or CD26 trait
Normal Probe
Mutant Probe
-28 CD17 CD26 CD19 CD35 IVSI-1 IVSI-5
N N N N N M N
N N N N N M N
-28 CD17 CD26 CD19 CD35 IVSI-1 IVSI-5
Compound heterozygote CD19/IVSI-1
Normal ProbeMutant Probe
Mutations covered by ViennaLab β-, α- thalassemia Globin StripAssays®
• Mass Spectrometry
• Melting Curve Analysis
• High-Resolution Melting Curve Analysis (HRM)
• Multiplex Ligation-dependent Probe Amplification (MLPA)
• Microarray assay
More DNA Analysis for β and α-Thalassemia
MassARRAYTM
High throughput SNP detection
Primer extension + Mass spectrometry
TOF v α 1/m
Matrix-Assisted Laser Desorption/ Ionization (MALDI)
• Biomolecules are mixed with a matrix (usually an organic acid) and dried on sample holder.
• A laser is focused onto a small area of the sample, and a pulse desorbs a plume of analyte and associated cations that are then accelerated into the analyzer.
Matrix-Assisted Laser-Desorption / Ionization Time-of-Flight Mass Spectrometry
MALDI-TOF MS • Improved mass resolution in
MALDI-TOF MS has been obtained by the utilization of a reflectron.
• The reflectron, located at the end of the flight tube, is used to compensate for the difference in flight times of the same m/z ions of slightly different kinetic energies by means of an ion reflector.
1020 1066 1112 1158 1204 1250Mass (m/z)
0
2.1E+4
0
10
20
30
40
50
60
70
80
90
100
% In
tens
ity
1087.63
1071.56
1178.65
1088.641072.561149.67
1179.651126.581074.57 1150.68
1192.671127.591089.64 1180.661073.57 1144.70 1193.681098.57 1151.68 1226.63
α
β
G γ
Aγ
β
α
1020 1066 1112 1158 1204 1250Mass (m/z)
0
2.1E+4
0
10
20
30
40
50
60
70
80
90
100
% In
tens
ity
1087.63
1071.56
1178.65
1088.641072.561149.67
1179.651126.581074.57 1150.68
1192.671127.591089.64 1180.661073.57 1144.70 1193.681098.57 1151.68 1226.63
1020 1066 1112 1158 1204 1250Mass (m/z)
0
2.1E+4
0
10
20
30
40
50
60
70
80
90
100
% In
tens
ity
1087.63
1071.56
1178.65
1088.641072.561149.67
1179.651126.581074.57 1150.68
1192.671127.591089.64 1180.661073.57 1144.70 1193.681098.57 1151.68 1226.63
α
β
G γ
Aγ
β
α
Globin chain separation by mass spectrometry
MILD % Hb F – 39
MILD % Hb F – 36
Evaluate to what extent polymorphism within the β-globin gene region contributes to variation in disease severity
β β αGγAγ β+γXmn I -/-
β β αGγAγ β+γXmn I +/+ 665LP
006M
Association Xmn I genotype with Gamma Expression in β-Thalasemia/HbE
MS Genotyping
HbE 6565
WT at HbE
6894
HbA 6968
HbS 7931
Wt at HbE 6894
β-globin biplex mutation assay
HbS/S & Wt/Wt
HbA/A & Wt/HbE
Several MALDI-TOF mass spectrometry spectra are shown depicting various allele combinations called during the β-globin biplex mutation assay. In this biplex assay, genotypes were called at codons 5,6 & 26 of the β-globin gene.
Cycle #
Log
Targ
et D
NA
Theoretical
Amplification is exponential, but the exponential increase is limited:
Real-Time PCR allows us to ‘see’ the exponential phase so we can calculate how much we started with.
● A linear increase follows exponential ● Eventually plateaus Real Life
Threshold
CT
Reality vs Theory in PCR
Primer & probe set performance assay for ���tri-plex qPCR of α-, β-, and γ-Globin
Ten-fold serial dilution of standard plasmid cDNA from a tri-plex qPCR
100 ng/µl, first step
Concentration of cDNA dilution series corresponding to total RNA input in first step. 2 µl of cDNA was used in each 25 µl qPCR reaction
10 ng/µl 1 ng/µl 100 pg/µl 1 pg/µl 10 pg/µl
α-, β-, and γ-Globin Standard Graph
qRT-PCR primers sequence
Correctly/aberrantly spliced βE-globin mRNA
α/non α-globin mRNA ratio
Summary
Conventional PCR
DNA extraction
PCR amplification
Agarose gel electrophoresis Post-PCR
Pre-PCR
PCR
M = 100 bp DNA ladder plus Lane 1 = α-thalassemia 1 heterozygote (–SEA type) Lane 2 = Not found α-thalassemi 1 (–SEA type)
1200 1500 2000
M 1 2
Normal
α-thalassemia 1
Gap PCR for α-thalassemia
II: Melting Curve!I: DNA Amplification !
85.5 °C
Melting Curve Analysis
Melting Curve Analysis
α-Thalassemia diagnosis by melting curve analysis
Summary
Point mutation genotyping by High Resolution Melting Curve Analysis (HRM)
Agarose Gel Electrophoresis
High Resolution Melting Curve Analysis
DNA from known genotype, wild type, heterozygote and homozygote mutant
Result of unknown samples
Control 41/42(-CTTT) trait Normal Unknown/ HBA2=4.8%
Beta thalassemia gene scanning: a case of beta thal trait
Normalized and temperature-shifted difference plot
Tm Normal: 75.56 C T rait 3.5 kb: 76.45 / 78.15 C Homoz 3.5 kb: 78.05 C
HRMA beta thalassemia 3.4 kb deletion
normal homozygous beta Thal 3.5 kb deletion
Trait 3.5
ζ ψζ αDψα1 α2 α1 θ
HBZ HBZps HBD HBA1ps HBA2 HBA1 HBQ
150k 160k 170k 140k 180k
Luc7L C16orf35 w
w
w
w 3’HVR interζHVR
- -MC --CAL --Dutch I --THAI --MED II --FIL --KOL --BRIT -(α)20.5 --MA --SA --MED 1 --SEA --PP --CANT --SPAN --GEO -(α)5.2
Example: deletions that cause α0-thalassemia
- -00682 - -00591 - -00653 - -00690 --AW
Novel deletions detected by MLPA
Multiplex Ligation-dependent Probe Amplification (MLPA)
C.L.Harteveld Hemoglobinopathies Laboratory
deletion
Deletion of 1 allele: half the amount of PCR product
MLPA
C.L.Harteveld Hemoglobinopathies Laboratory
ABI 3730 normal control
heterozygote mutant
MLPA
Peak height normal Peak height patient = 1 ratio No deletion:
One allele deleted: ratio = 0.5
Both alleles deleted: ratio = 0
Multiplex Ligation-dependent Probe Amplification
C.L.Harteveld, LUMC !
Probe hybridisation Probe ligation PCR of ligated probes with tag primers
Target A Target A
Target B Target B
3’
3’
3’
3’
5’
5’
5’
5’
5’ tag1 tag2 tag2 tag1
stuffer sequence hybridisation sequence
primer sequence
primer sequence
5’ 3’
3’
Micro-array = large number of DNA sequences, immobilized on a solid surface in an ordered
manner
Target cell !
In-situ synthesized oligonucleotides
micro-array slide
Labeled DNA!
scanning!
Image Generation !
!
Hybridization, wash!
3.7 Kb deletion type by gap PCR!
4.2 Kb deletion type by gap PCR!